MARKET

Madrigal Pharmaceuticals gets first FDA approval for drug targeting liver disease MASH

by TexasDigitalMagazine.com
written by TexasDigitalMagazine.com




Madrigal Pharmaceuticals on Thursday received FDA approval for the first drug designed to treat a severe liver disease known as MASH.



Source link

You may also like

The Mike Tyson-Jake Paul fight was a payday...

The S&P 500 has come to a major...

Rivian, Volkswagen joint venture is upsized to $5.8...

I’m 67, married and have two mortgages worth...

Trump has a ‘super clear’ mandate on taxes...

My boyfriend struggled to come up with a...

Here’s how ETF investors can lock in higher...

Vans maker VF Corp. rallies on results, and...

Dow, S&P 500 fall Friday — but Nasdaq...

‘God works in mysterious ways’: I became a...